IP Library Granted Patent US 12,569,331
Granted Patent B2
US 12,569,331 · App. 18/119,166 · Granted Mar 10, 2026

Implant with a visual indicator of a barrier layer

Inventors: Rolando Mora (Alajuela, CR); Salvador Dada (Alajuela, CR); Juan Jose Chacon (Alajuela, CR)
Assignee: Establishment Labs S.A.
A61F2/12B29C41/02B29C41/22A61F2210/0076A61F2240/001A61F2250/0036A61F2250/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,569,331
App. No.
18/119,166
Granted
Mar 10, 2026
Kind
B2
Abstract

An implantable soft tissue prosthesis device comprising a silicone elastomer-shell filled with silicone gel or liquid, which among the layers that constitute its shell includes a barrier layer formed of a low permeability silicone, which impedes the bleeding or diffusion of the silicone gel from the inside of the implant to its surroundings through the shell. This barrier layer is given a coloration different to the other layers of the shell, making it visible in the finished product. The coloration of the barrier layer gives the fabricator of the implant as well as to medical personnel, the possibility to identify the presence of the barrier layer and its homogeneity, improving the safety of the device.

Claims (24)

1 . An implantable soft tissue prosthesis device comprising:

a multilayer shell having one or more layers, the multilayer shell including a silicone elastomer, including:

the multilayered shell enclosing a lumen filled with at least one of a fluid or a gel;

wherein at least one layer of the multilayer shell includes a homogenous low diffusion barrier layer, the homogeneous low diffusion barrier layer nestled between at least two layers of the one or more layers; and

wherein the homogenous low diffusion barrier layer includes one or more pigments dispersed in a vinyldimethyl-terminated polydimethylsiloxane polymer.

2 . The implantable soft tissue prosthesis device of claim 1 , wherein the at least one of the fluid or the gel includes a silicone.

3 . The implantable soft tissue prosthesis device of claim 1 , wherein the one or more pigments is different than other layers of the multilayer shell.

4 . The implantable soft tissue prosthesis device of claim 1 , wherein the multilayer shell includes the one or more layers formed from an elastomer.

5 . The implantable soft tissue prosthesis device of claim 1 , wherein each layer of the multilayer shell has a uniform thickness.

6 . The implantable soft tissue prosthesis device of claim 1 , wherein the homogenous low diffusion barrier layer is visible by a health professional.

7 . A multilayered, flexible implant, comprising:

a shell having one or more layers, surrounding a lumen, including:

at least one elastomer layer; and

a low diffusion barrier layer nestled between at least two layers of the one or more layers, the low diffusion barrier layer having a color different than the at least one elastomer layer and formed from a material including polydimethylsiloxane and a pendant chemical group including one of a phenyl or fluorine group;

wherein the low diffusion barrier layer includes a color dispersion including diphenyl group; and

a liquid or gel disposed within the lumen of the shell.

8 . The multilayered, flexible implant of claim 7 , wherein the low diffusion barrier layer is in contact with the liquid or gel.

9 . The multilayered, flexible implant of claim 7 , wherein the at least one elastomer layer is made of a silicone elastomer.

10 . The multilayered, flexible implant of claim 7 , wherein the low diffusion barrier layer is visible by observation by health professionals.

11 . The multilayered, flexible implant of claim 7 , wherein the pendant chemical group includes a fluorine group.

12 . The multilayered, flexible implant of claim 7 , wherein the low diffusion barrier layer includes a pigment dispersed in a vinyldimethyl-terminated polydimethylsiloxane polymer.

13 . The multilayered, flexible implant of claim 7 , wherein the multilayered, flexible implant is a breast implant.

14 . The multilayered, flexible implant of claim 7 , wherein each layer of the one or more layers and the shell has a uniform thickness.

15 . The multilayered, flexible implant of claim 7 , wherein the low diffusion barrier layer is formed from a silicone elastomer comprising a polysiloxane backbone and having a minimum mole percentage of 10 % of a substituted or pendant chemical group that is configured to minimize permeation of silicone from the lumen.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2023
From: ORTIZ, ROLANDO MORA; DADA, SALVADOR; CHACON, JUAN JOSE
To: ESTABLISHMENT LABS S.A.
Reel/Frame 063075/0437 →
Continuity (5)
Continuation 16143595 · Sep 27, 2018
Continuation 14598762 · Jan 16, 2015
Continuation 13412221 · Mar 5, 2012
Provisional Application 61449931 · Mar 7, 2011
Related Publication 20230285138A1 · Sep 14, 2023
References Cited (76)
US 3366975A · Pangman · 1968 [cited by applicant]
US 4455691A · Van Aken Redinger · 1984 [cited by examiner]
US 4650487A · Chaglassian · 1987 [cited by applicant]
US 4764118A · Touati · 1988 [cited by examiner]
US 4773909A · Chaglassian · 1988 [cited by applicant]
US 4795463A · Gerow · 1989 [cited by applicant]
US 4960425A · Yan · 1990 [cited by examiner]
US 5630844A · Dogan · 1997 [cited by applicant]
US 5904886A · Stecker · 1999 [cited by examiner]
US 6187233B1 · Smith · 2001 [cited by applicant]
US 8104097B2 · Hamann · 2012 [cited by applicant]
US 8562679B2 · Rechenberg · 2013 [cited by examiner]
US 8708955B2 · Tilson · 2014 [cited by examiner]
US 10111744B2 · Mora · 2018 [cited by examiner]
US 11045307B2 · Quirós · 2021 [cited by examiner]
US 11109956B2 · Chacon Quiros · 2021 [cited by examiner]
US 11607306B2 · Mora et al. · 2023 [cited by applicant]
US 11672648B2 · Garcia · 2023 [cited by examiner]
US 20050044609A1 · Vistins · 2005 [cited by examiner]
US 20050079365A1 · Widenhouse · 2005 [cited by examiner]
US 20050149186A1 · Roballey · 2005 [cited by examiner]
US 20070104904A1 · Hamann · 2007 [cited by examiner]
US 20080243167A1 · Paganon et al. · 2008 [cited by applicant]
US 20080269555A1 · Paganon et al. · 2008 [cited by applicant]
US 20090030515A1 · Schuessler · 2009 [cited by examiner]
US 20090126074A1 · Mattesky · 2009 [cited by applicant]
US 20090162533A1 · Kirby et al. · 2009 [cited by applicant]
US 20090236771A1 · Mitchell et al. · 2009 [cited by applicant]
US 20090299374A1 · Tilson et al. · 2009 [cited by applicant]
US 20090299401A1 · Tilson · 2009 [cited by applicant]
US 20090301643A1 · Tilson · 2009 [cited by examiner]
US 20100028396A1 · Ward · 2010 [cited by examiner]
US 20100076437A1 · Tilson et al. · 2010 [cited by applicant]
US 20100152654A1 · Tilson et al. · 2010 [cited by applicant]
US 20100241152A1 · Tilson et al. · 2010 [cited by applicant]
US 20100241153A1 · Tilson et al. · 2010 [cited by applicant]
US 20100241178A1 · Tilson et al. · 2010 [cited by applicant]
US 20100257657A1 · Hamann et al. · 2010 [cited by applicant]
US 20100262218A1 · Deshmukh · 2010 [cited by applicant]
US 20110054636A1 · Gill · 2011 [cited by applicant]
US 20120124714A1 · Hamann · 2012 [cited by examiner]
US 20120232652A1 · Mora · 2012 [cited by examiner]
US 20130096676A1 · Boegershausen · 2013 [cited by examiner]
US 20150150675A1 · Mora · 2015 [cited by examiner]
US 20190099260A1 · Mora et al. · 2019 [cited by applicant]
US 20210259823A1 · Garcia · 2021 [cited by examiner]
US 20210346150A1 · Chacón Quirós · 2021 [cited by examiner]
US 20220055258A1 · Fei · 2022 [cited by examiner]
US 20220185872A1 · Medof · 2022 [cited by examiner]
“U.S. Appl. No. 13/412,221, Advisory Action mailed Dec. 17, 2014”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 13/412,221, Examiner Interview Summary mailed Nov. 1, 2013”, 4 pgs. [cited by applicant]
“U.S. Appl. No. 13/412,221, Final Office Action mailed Jul. 16, 2014”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 13/412,221, Final Office Action mailed Sep. 5, 2013”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 13/412,221, Non Final Office Action mailed Feb. 19, 2013”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 13/412,221, Non Final Office Action mailed Oct. 23, 2012”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 13/412,221, Notice of Non-Compliant Amendment mailed Jul. 24, 2013”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 13/412,221, Response filed Feb. 4, 2014 to Final Office Action mailed Sep. 5, 2013”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 13/412,221, Response filed Jul. 10, 2013 to Non Final Office Action mailed Feb. 19, 2013”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 13/412,221, Response filed Jul. 24, 2013 to Notice of Non-Compliant Amendment mailed Jul. 24, 2013”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 13/412,221, Response filed Dec. 12, 2014 to Final Office Action mailed Jul. 16, 2014”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 14/598,762, Final Office Action mailed Apr. 19, 2018”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 14/598,762, Final Office Action mailed Oct. 21, 2016”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 14/598,762, Non Final Office Action mailed Jan. 11, 2016”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 14/598,762, Non Final Office Action mailed Jul. 13, 2017”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 14/598,762, Notice of Allowance filed Jun. 27, 2018”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 14/598,762, Preliminary Amendment filed Jan. 16, 2015”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 14/598,762, Response filed Mar. 21, 2017 to Final Office Action mailed Oct. 21, 2016”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 14/598,762, Response filed Jun. 14, 2018 to Final Office Action mailed Apr. 19, 2018”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 14/598,762, Response filed Jul. 8, 2016 to Non Final Office Action mailed Jan. 11, 2016”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 14/598,762, Response filed Dec. 13, 2017 to Non Final Office Action mailed Jul. 13, 2017”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 16/143,595, Non Final Office Action mailed Jul. 5, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/143,595, Notice of Allowance mailed Nov. 17, 2022”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 16/143,595, Preliminary Amendment filed Sep. 27, 2018”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/143,595, Response filed Oct. 5, 2022 to Non Final Office Action mailed Jul. 5, 2022”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 16/143,595, Supplemental Preliminary Amendment filed Jun. 3, 2022”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 16/143,595, Supplemental Preliminary Amendment filed Dec. 26, 2018”, 7 pgs. [cited by applicant]